Skip to main content

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Wenbin Jiang

Wenbin Jiang is recorded as Board Member and CEO at Cytek Biosciences, Inc. (CTKB). The proxy statement of Cytek Biosciences, Inc. reports total compensation of $5,120,061 for Wenbin Jiang in fiscal 2025, including a base salary of $620,000. Disclosed compensation is on record for 6 fiscal years. Wenbin Jiang has spoken on 17 earnings calls across 1 company, most recently for Cytek Biosciences, Inc. on August 5, 2026.

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at Cytek Biosciences, Inc.

Other people whose current roles at this company are on record from its filings.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2025 Cytek Biosciences, Inc. (CTKB) $620,000 $5,120,061
2024 Cytek Biosciences, Inc. (CTKB) $599,083 $6,084,671
2023 Cytek Biosciences, Inc. (CTKB) $578,000 $4,939,242
2022 Cytek Biosciences, Inc. (CTKB) $524,435 $3,914,142
2021 Cytek Biosciences, Inc. (CTKB) $375,131 $4,818,502
2020 Cytek Biosciences, Inc. (CTKB) $241,487 $422,221

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.

Show 5 earlier activities